Cargando…

Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD

Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis and progresses to non-steatohepatitis (NASH) when the liver displays overt inflammatory damage. Increasing evidence has implicated critical roles for dysbiosis and microbiota-host interactions in NAFLD pathophysiology. I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Xiaofan, Zheng, Juan, Zhang, Shixiu, Wang, Baozhen, Wu, Chaodong, Guo, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403443/ https://www.ncbi.nlm.nih.gov/pubmed/32850884 http://dx.doi.org/10.3389/fmed.2020.00361

Ejemplares similares

Advances in Unhealthy Nutrition and Circadian Dysregulation in Pathophysiology of NAFLD
por: Guo, Xin, et al.
Publicado: (2021)

Gut Microbiota and Metagenomic Advancement in Digestive Disease
por: Yu, Jinsheng, et al.
Publicado: (2016)

Gut Microbiota and Lifestyle Interventions in NAFLD
por: Houghton, David, et al.
Publicado: (2016)

Gut Microbiota: Association with NAFLD and Metabolic Disturbances
por: Lau, E., et al.
Publicado: (2015)

Chlorogenic Acid Improves NAFLD by Regulating gut Microbiota and GLP-1
por: Shi, Ameng, et al.
Publicado: (2021)

Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications
por: Chen, Jiezhong, et al.
Publicado: (2020)

Nutritional Approach Targeting Gut Microbiota in NAFLD—To Date
por: Moszak, Małgorzata, et al.
Publicado: (2021)

Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions
por: Hrncir, Tomas, et al.
Publicado: (2021)

The Positive Effects of Grifola frondosa Heteropolysaccharide on NAFLD and Regulation of the Gut Microbiota
por: Li, Xin, et al.
Publicado: (2019)

Targeting T Cell Subtypes for NAFLD and NAFLD-Related HCC Treatment: An Opinion
por: Zhang, Chunye, et al.
Publicado: (2021)

CONSORT-Characteristics and metabolic phenotype of gut microbiota in NAFLD patients
por: Ge, Haize, et al.
Publicado: (2022)

Effect of Sheng-Jiang Powder on Gut Microbiota in High-Fat Diet-Induced NAFLD
por: Li, Juan, et al.
Publicado: (2020)

Editorial: The heart of NAFLD
por: Chew, Nicholas W. S., et al.
Publicado: (2023)

Role of Gut Microbiota-Gut Hormone Axis in the Pathophysiology of Functional Gastrointestinal Disorders
por: Fukui, Hirokazu, et al.
Publicado: (2018)

The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD
por: Soderborg, Taylor K., et al.
Publicado: (2018)

The identification of metabolites from gut microbiota in NAFLD via network pharmacology
por: Oh, Ki-Kwang, et al.
Publicado: (2023)

Differential Effects of Dietary White Meat and Red Meat on NAFLD Progression by Modulating Gut Microbiota and Metabolites in Rats
por: Li, Juan, et al.
Publicado: (2022)

The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC
por: Song, Qian, et al.
Publicado: (2022)

Role of gut microbiota-derived signals in the regulation of gastrointestinal motility
por: Zheng, Zhipeng, et al.
Publicado: (2022)

Editorial: Gut microbiota and gastrointestinal disorders
por: Yadegar, Abbas, et al.
Publicado: (2022)

Akkermansia muciniphila and Bifidobacterium bifidum Prevent NAFLD by Regulating FXR Expression and Gut Microbiota
por: Nian, Fulin, et al.
Publicado: (2023)

Editorial: Advances in the Pathophysiology, Diagnosis, and Treatment of Dry Eye Disease
por: Lu, Yiteng, et al.
Publicado: (2022)

Current Research on the Pathogenesis of NAFLD/NASH and the Gut–Liver Axis: Gut Microbiota, Dysbiosis, and Leaky-Gut Syndrome
por: Kobayashi, Takashi, et al.
Publicado: (2022)

Gut microbiota and atopic dermatitis: a two-sample Mendelian randomization study
por: Xue, Yan, et al.
Publicado: (2023)

Dysregulated hepatic lipid metabolism and gut microbiota associated with early-stage NAFLD in ASPP2-deficiency mice
por: Xie, Fang, et al.
Publicado: (2022)

Thioredoxin/Glutaredoxin Systems and Gut Microbiota in NAFLD: Interplay, Mechanism, and Therapeutical Potential
por: Zhu, Minghui, et al.
Publicado: (2023)

Dysbiosis in gastrointestinal pathophysiology: Role of the gut microbiome in Gulf War Illness
por: Slevin, Elise, et al.
Publicado: (2023)

Gut microbiota and microbiota-based therapies for Clostridioides difficile infection
por: Chopra, Teena, et al.
Publicado: (2023)

Gut microbiota-modulating agents in alcoholic liver disease: Links between host metabolism and gut microbiota
por: Jung, Jang Han, et al.
Publicado: (2022)

Associations of Gut Microbiota and Fatty Metabolism With Immune Thrombocytopenia
por: Yu, Xiaomin, et al.
Publicado: (2022)

Role of Oxidative Stress and Lipid Peroxidation in the Pathophysiology of NAFLD
por: Martín-Fernández, Marta, et al.
Publicado: (2022)

Perinatal High-Salt Diet Induces Gut Microbiota Dysbiosis, Bile Acid Homeostasis Disbalance, and NAFLD in Weanling Mice Offspring
por: Guo, Qing, et al.
Publicado: (2021)

Role of gut microbiota in type 2 diabetes pathophysiology
por: Gurung, Manoj, et al.
Publicado: (2020)

Pathophysiology of Type 1 Diabetes and Gut Microbiota Role
por: Del Chierico, Federica, et al.
Publicado: (2022)

Targets of statins intervention in LDL-C metabolism: Gut microbiota
por: Sun, ChangXin, et al.
Publicado: (2022)

Liuzijue training improves hypertension and modulates gut microbiota profile
por: Wu, Sha, et al.
Publicado: (2023)

The roles of the gut microbiota–miRNA interaction in the host pathophysiology
por: Li, Meihong, et al.
Publicado: (2020)

Insights Into Extracellular Vesicles as Biomarker of NAFLD Pathogenesis
por: Garcia-Martinez, Irma, et al.
Publicado: (2020)

Editorial: New Insights Into Understanding and Managing NAFLD
por: Escribano, Óscar, et al.
Publicado: (2021)

COVID-19 and MAFLD/NAFLD: An updated review
por: Nowroozi, Ali, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mdarkh5agp41ape90l5pv7b3p8